Все публикации

0:02:35

Dr Eads on the Rationale for ECOG-ACRIN EA2174 in Esophageal/GEJ Adenocarcinoma

0:02:59

Dr Chalasani on the Potential Utility of Eftilagimod Alpha in HER2–/HER2-Low Breast Cancer

0:01:34

ASCO 2024 Applications in Gynecologic Oncology: Episode 3

0:01:11

Dr. Lopes on the Rationale to Stop Immunotherapy After 2 Years in Lung Cancer

0:09:37

Novel Treatments in HER2-Positive Breast Cancer

0:02:25

Dr. Davies on Carfilzomib Dosage in Multiple Myeloma

0:06:50

Ep. 6: Identifying Nonmetastatic CRPC

0:08:47

Maintaining Quality of Life in Metastatic CRPC

0:09:18

Therapy Options for Hepatitis B/C–Related HCC

0:03:04

Biology of Clear Cell Renal Cell Carcinoma

0:08:38

The Use of Ruxolitinib in Myelofibrosis

0:08:07

Lenalidomide in Del 5q MDS

0:06:36

MDS: Low-Risk Disease Treatment Options

0:05:49

Neoadjuvant Treatment for Triple-Negative Breast Cancer

0:04:26

Cirrhosis Prognosis: The Child-Pugh Score

0:05:54

Initial Systemic Therapy for Metastatic Colorectal Cancer

0:08:54

Iron Chelation Therapy for MDS

0:01:20

Dr. Corcoran on Targeting HER2 Amplification in CRC

0:07:17

Role of Phlebotomy in Polycythemia Vera

0:05:21

When to Initiate Therapy for Follicular Lymphoma

0:08:29

Approaching HER2 Testing in Breast Cancer

0:06:09

Signs of Progressive Polycythemia Vera

0:06:01

Common Signs and Symptoms of Polycythemia Vera

0:06:01

Diagnosis of Myelodysplastic Syndrome